Deep Brain Stimulation for mental disorders

Category: Archive Equipment Intracorporeal devices Mental disorders Parkinsons
Tag: #brain #deep brain stimulation (DBS) #medtronic en #nervous system #neurostimulation #syndromes
Share:

The idea that deep brain stimulation could become useful in the treatment of a variety of drug-resistant mental disorders is nothing new. Until now it has been mainly used for the treatment of extrapyramidal and cerebellar disorders such as ataxia and Parkinson's . The American Association of Neurosurgeons (AANS), is studying and evaluating deep brain stimulation (DBS) point useful for the treatment of severe drug-resistant depressions and obsessive compulsive disorders (OCD).

From the Medtronic statement: The data represent the largest and longest running clinical experience with DBS in psychiatric disorders and were collected through collaborative research from several institutions and associations. All of the studies presented use the Medtronic DBS system to stimulate a target within the brain: the postcentral gyrus internal capsule, which is a central node in the neural circuits that regulate mood and anxiety. The data presented on 43 patients are the result of more than 10 years of work. These data represent the largest number and longest evaluation in patients with psychiatric disorders who have undergone DBS implant, with very long follow-up: Dr Rezai, who represented the international working group of physicians studying the DBS as a therapy for neuropsychiatric treatment, he said: "While treatment with DBS in OCD and depressive syndromes requires further clinical evaluation, the experience thus far is encouraging and indicates that DBS can help severely disabled and suffering patients who have ran out of other treatment options." [via medgadget ]

Published: 2022-12-28From: Marketing

You may also like

New therapeutic frontiers for Multiple Sclerosis

From personal experience I have been able to verify that in recent years Multiple Sclerosis (MS) increasingly affects early onset, therefore very young people, but I have also been able to appreciate, having worked in a Research and Treatment Center for Multiple Sclerosis, that State-of-the-art therapies visually slow its progression, thus also increasing the quality… Continua a leggere New therapeutic frontiers for Multiple Sclerosis

2022-12-28Marketing

A simple eye exam can track the progress of multiple sclerosis

A quick scan of the eye may offer a simple and painless way for multiple sclerosis patients to track the progress of the disease. Researchers at the Johns Hopkins Multiple Sclerosis Center in Baltimore have discovered that by observing the nerve fibers in the back of the retina, one can get a fairly accurate picture… Continua a leggere A simple eye exam can track the progress of multiple sclerosis

2022-12-28Marketing

Hopes from gene therapy for Parkinson's

Yesterday World Parkinson's Day was celebrated, a conference organized in the Campidoglio by the Italian Parkinsonian Association (AIP). The data reported is certainly not comforting: in Italy alone there are four hundred thousand people with Parkinson's disease, a disease that affects 3 people out of every thousand (about 1% of the over 65s) and which… Continua a leggere Hopes from gene therapy for Parkinson's

2022-12-28Marketing

Depression is the first sign of Parkinson's

Here is the news that many have been waiting for, at least anyone who has a relative or friend affected by this terrible disease. The diagnosis of Parkinson 's can now be anticipated and perhaps caught in time and treated. At the XI European Congress of Neurology in Brussels it was in fact said that… Continua a leggere Depression is the first sign of Parkinson's

2022-12-28Marketing